Mayo Clinic is publishing commercialized analytics tools on the Apervita platform, offering other healthcare organizations the chance to leverage its clinical knowledge.

"We are sharing our algorithms to empower others to deliver patients the best health care," said Paul Friedman, MD, director of the Cardiac Electronic Implantable Device Lab at Mayo Clinic, in a press statement.

Mayo's analytics algorithms cover a large number of specialties, such as cardiovascular, pulmonology, and oncology. The Apervita market makes those tools accessible to other health professionals.

"At Mayo, one of our most scalable assets is our knowledge," he added. "We have found sharing knowledge significantly improves the efficacy of care delivery, improving quality and driving down costs. Sudden cardiac arrest is a leading cause of death among adults over the age of 40. One algorithm we are sharing through the Apervita Market assists physicians by quickly sifting through data, and automatically identifying patients at risk for sudden cardiac arrest for an appropriate consultation."

Cloud-based Apervita – which recently completed an $18 million Series A funding round, led by GE Ventures and Baird Capital with participation from Pritzker Group Venture Capital, Math Ventures and existing investors – enables the sharing of algorithms, quality and safety measures, pathways, and protocols. The platform lets organizations subscribe to analytics, and easily integrate them into their workflow.

"Mayo Clinic has one of the richest portfolios of health knowledge in the world, which combined could have extraordinary benefits for the world's health," said Apervita CEO Paul Magelli, in a press statement. "Patients and health professionals have the most to gain when leading organizations like Mayo publish on Apervita."